Tocilizumab for the treatment of COVID-19: Evidence review of the clinical benefit and harm

Parrish, AReubenson, GBlockman, MCohen, KGray, AKredo, TDe Waal, RMaartens, GNel, JRees, H2025-01-042025-01-042021-03-05https://hdl.handle.net/11288/598006enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Tocilizumab for the treatment of COVID-19TocilizumabClinical benefit of tocilizumabClinical harms of tocilizumabTocilizumab for the treatment of COVID-19: Evidence review of the clinical benefit and harmTechnical Report